mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
-0.2 |
0.2 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |